Cherrydale Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$274K Buy
2,134
+1
+0% +$117 0.07% 69
2026
Q1
$257K Sell
2,133
-97
-4% -$11.2K 0.08% 59
2025
Q4
$235K Buy
+2,230
New +$209K 0.07% 67
2025
Q2
Sell
-2,412
Closed -$216K 81
2025
Q1
$216K Buy
2,412
+54
+2% +$5.04K 0.09% 63
2024
Q4
$235K Sell
2,358
-6
-0.3% -$619 0.09% 62
2024
Q3
$268K Sell
2,364
-107
-4% -$12.7K 0.11% 51
2024
Q2
$306K Buy
2,471
+535
+28% +$68.9K 0.13% 48
2024
Q1
$255K Hold
1,936
0.12% 49
2023
Q4
$211K Buy
+1,936
New +$201K 0.11% 45
2023
Q3
Sell
-1,778
Closed -$205K 48
2023
Q2
$205K Buy
+1,778
New +$202K 0.14% 40

Other funds holding MRK

Cherrydale Wealth Management's MRK Position: Q2 2026 in Review

Cherrydale Wealth Management increased its Merck (MRK) stake by 0.05% in Q2 2026, buying an estimated $117 and bringing the position to 2,134 shares worth $274K. The position accounts for 0.07% of the portfolio, ranked #69.

Cherrydale Wealth Management first reported a position in MRK in Q2 2023 and has held it in 10 quarters since. The position peaked at $306K in Q2 2024. 3,819 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Cherrydale Wealth Management held 2,134 shares of Merck worth $274K as of Q2 2026.
  • Cherrydale Wealth Management bought 1 Merck share in Q2 2026, an estimated $117.
  • Merck made up 0.07% of Cherrydale Wealth Management's portfolio in Q2 2026, its #69 holding.
  • Cherrydale Wealth Management first reported a position in Merck in Q2 2023 and has held it in 10 quarters since.
  • Cherrydale Wealth Management's Merck position peaked at $306K in Q2 2024.
  • 3,819 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Cherrydale Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.